Efficacy of palonosetron versus ramosetron on preventing opioid-based analgesia-related nausea and vomiting after lumbar spinal surgery: A prospective, randomized, and double-blind trial

Spine

Volumn 39, Issue 9, 2014, Pages

  Roh, Go Un ^a   Yang, So Young ^b   Shim, Jae Kwang ^a   Kwak, Young Lan ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

analgesia; anti emetics; palonosetron; patient controlled; postoperative nausea and vomiting; ramosetron

Indexed keywords

FENTANYL; KETOROLAC; PALONOSETRON; RAMOSETRON; ANTIEMETIC AGENT; BENZIMIDAZOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; QUINUCLIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SPINE SURGERY; TREATMENT OUTCOME; URINE RETENTION; ANALGESIA; CHEMICALLY INDUCED; LUMBAR VERTEBRA; MIDDLE AGED; ORTHOPEDIC SURGERY; PROSPECTIVE STUDY; SURGERY;

ADULT; AGED; ANALGESICS, OPIOID; ANTIEMETICS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOQUINOLINES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PAIN MANAGEMENT; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; QUINUCLIDINES; TREATMENT OUTCOME;

EID: 84899658477     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0000000000000236     Document Type: Article

References (31)

1. Cata JP, Noguera EM, Parke E, et al. Patient-controlled epidural analgesia (PCEA) for postoperative pain control after lumbar spine surgery. J Neurosurg Anesthesiol 2008; 20: 256-60.
2. Momeni M, Crucitti M, De Kock M. Patient-controlled analgesia in the management of postoperative pain. Drugs 2006; 66: 2321-37.
3. Wu CL, Rowlingson AJ, Partin AW, et al. Correlation of postoperative pain to quality of recovery in the immediate postoperative period. Reg Anesth Pain Med 2005; 30: 516-22.
4. Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth 2011; 107 (suppl 1): i27-40.
5. Mizuno J, Morita S, Hanaue N, et al. Intravenous patient-controlled analgesia (IV-PCA) for relief of postoperative pain. Masui 2011; 60: 908-12.
6. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
7. Roberts GW, Bekker TB, Carlsen HH, et al. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 2005; 101: 1343-8.
8. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71, table of contents.
9. Jellish WS, Leonetti JP, Sawicki K, et al. Morphine/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery. Otolaryngol Head Neck Surg 2006; 135: 175-81.
10. Moon YE, Joo J, Kim JE, et al. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. Br J Anaesth 2012; 108: 417-22.
11. Kim SI, Kim SC, Baek YH, et al. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Br J Anaesth 2009; 103: 549-53.
12. Rabasseda X. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc) 2002; 38: 75-89.
13. Ogata A, Yamada Y, Sugiura M, et al. Analysis of 5-HT3 receptor antagonist, ramosetron hydrochloride, based on receptor occupancy considering its active metabolite. Yakugaku Zasshi 2001; 121: 793-8.
14. Yang LP, Scott LJ. Palonosetron: in the prevention of nausea and vomiting. Drugs 2009; 69: 2257-78.
15. Muchatuta NA, Paech MJ. Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manage 2009; 5: 21-34.
16. Candiotti KA, Kovac AL, Melson TI, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107: 445-51.
17. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-84.
18. Walder B, Schafer M, Henzi I, et al. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand 2001; 45: 795-804.
19. Tramer MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I. Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesthesiol Scand 2001; 45: 4-13.
20. Choi YS, Shim JK, Yoon do H, et al. Effect of ramosetron on patient-controlled analgesia-related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine 2008; 33: E602-6.
21. Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003; 14: 1570-7.
22. Park SK, Cho EJ. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res 2011; 39: 399-407.
23. Kranke P, Eberhart LH, Apfel CC, et al. Tropisetron for prevention of postoperative nausea and vomiting: a quantitative systematic review. Der Anaesthesist 2002; 51: 805-14.
24. Kovac AL, Eberhart L, Kotarski J, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 2008; 107: 439-44.
25. Roewer N, Apfel CC. New facts on the risks of aspiration?. Anas-thesiol Intensivmed Notfallmed Schmerzther 2002; 37: 509-11.
26. Ito H, Akuzawa S, Tsutsumi R, et al. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), Granisetron and Ondansetron in rat vagus nerve and cerebral cortex. Neuropharmacology 1995; 34: 631-7.
27. Choi DK, Chin JH, Lee EH, et al. Prophylactic control of postoperative nausea and vomiting using ondansetron and ramosetron after cardiac surgery. Acta Anaesthesiol Scand 2010; 54: 962-9.
28. Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68.
29. Durila M, Bronsky J, Harustiak T, et al. Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography). BMC Anesthesiol 2012; 12: 12.
30. Chia YY, Kuo MC, Liu K, et al. Does postoperative pain induce emesis? Clin J Pain 2002; 18: 317-23.
31. Rosenstock CV, Thogersen B, Afshari A, et al. Awake fiberoptic or awake video laryngoscopic tracheal intubation in patients with anticipated difficult airway management: a randomized clinical trial. Anesthesiology 2012; 116: 1210-6.